Cargando…
Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
A 56-year-old Japanese man with liver cirrhosis (LC) due to hepatitis C virus was admitted to our hospital for radiofrequency ablation of residual tumor following lusutrombopag administration. Laboratory tests revealed thrombocytopenia and leukopenia. The patient’s LC was managed, and he was classif...
Autores principales: | Sakamaki, Akira, Watanabe, Takayuki, Abe, Satoshi, Kamimura, Kenya, Tsuchiya, Atsunori, Takamura, Masaaki, Kawai, Hirokazu, Yamagiwa, Satoshi, Terai, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429890/ https://www.ncbi.nlm.nih.gov/pubmed/28324272 http://dx.doi.org/10.1007/s12328-017-0735-2 |
Ejemplares similares
-
Spontaneous regression of hepatocellular carcinoma: A mini-review
por: Sakamaki, Akira, et al.
Publicado: (2017) -
Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
por: Kamimura, Kenya, et al.
Publicado: (2017) -
Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies
por: Kobayashi, Takamasa, et al.
Publicado: (2018) -
Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy
por: Kobayashi, Takamasa, et al.
Publicado: (2018) -
Renal Impairment in Chronic Hepatitis B: A Review
por: Kamimura, Hiroteru, et al.
Publicado: (2018)